Catalyst Wire Dossier Catalyst Wire Dossier

Bimagrumab

bimagrumab · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Bimagrumab, covering 2015-01-07 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity [Phase 2]

See pricing